Selective transmission of R5 HIV-1 variants: where is the gatekeeper?
Open Access
- 27 January 2011
- journal article
- review article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 9 (S1) , S6
- https://doi.org/10.1186/1479-5876-9-s1-s6
Abstract
To enter target cells HIV-1 uses CD4 and a coreceptor. In vivo the coreceptor function is provided either by CCR5 (for R5) or CXCR4 (for X4 HIV-1). Although both R5 and X4 HIV-1 variants are present in body fluids (semen, blood, cervicovaginal and rectal secretions), R5 HIV-1 appears to transmit infection and dominates early stages of HIV disease. Moreover, recent sequence analysis of virus in acute infection shows that, in the majority of cases of transmission, infection is initiated by a single virus. Therefore, the existence of a “gatekeeper” that selects R5 over X4 HIV-1 and that operates among R5 HIV-1 variants has been suggested. In the present review we consider various routes of HIV-transmission and discuss potential gatekeeping mechanisms associated with each of these routes. Although many mechanisms have been identified none of them explains the almost perfect selection of R5 over X4 in HIV-1 transmission. We suggest that instead of one strong gatekeeper there are multiple functional gatekeepers and that their superimposition is sufficient to protect against X4 HIV-1 infection and potentially select among R5 HIV-1 variants. In conclusion, we propose that the principle of multiple barriers is more general and not restricted to protection against X4 HIV-1 but rather can be applied to other phenomena when one factor has a selective advantage over the other(s). In the case of gatekeepers for HIV-1 transmission, the task is to identify them and to decipher their molecular mechanisms. Knowledge of the gatekeepers‘ localization and function may enable us to enhance existing barriers against R5 transmission and to erect the new ones against all HIV-1 variants.Keywords
This publication has 201 references indexed in Scilit:
- HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo modelMucosal Immunology, 2010
- Movements of HIV-Virions in Human Cervical MucusBiomacromolecules, 2009
- Modeling sequence evolution in acute HIV-1 infectionJournal of Theoretical Biology, 2009
- Use of human tissue explants to study human infectious agentsNature Protocols, 2009
- Setting the stage: host invasion by HIVNature Reviews Immunology, 2008
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infectionProceedings of the National Academy of Sciences, 2008
- Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B virusesVirology, 2008
- HIV infection and the gastrointestinal immune systemMucosal Immunology, 2007
- Initial Events in Establishing Vaginal Entry and Infection by Human Immunodeficiency Virus Type-1Immunity, 2007
- Rapid transport of large polymeric nanoparticles in fresh undiluted human mucusProceedings of the National Academy of Sciences, 2007